Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02024698 · ClinicalTrials.gov registry record · NA

Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist

A NA study, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT02024698: Completed NA study, sponsored by CooperVision.

NCT02024698 is a NA study that has completed, run by CooperVision. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02024698, a NA study, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

The objective of this study is to compare the clinical performance of ProClear 1-Day versus 1-Day Acuvue Moist each for one week of daily disposable wear.

Primary Outcome

Subjective Assessment of comfort on insertion at baseline for each pair using questionnaire and rated on subjective response scale. (0-10; 0= very uncomfortable, 10=cannot feel)

Interventions

  • DEVICE etafilcon A
  • DEVICE omafilcon A

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2014-01
Est. Completion 2014-03
Phase NA
CooperVision

64 total trials

What the finished NCT02024698 record still lists

NCT02024698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which etafilcon A is the first listed.

NCT02024698 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02024698 about?

NCT02024698 is a clinical study titled "Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist". The objective of this study is to compare the clinical performance of ProClear 1-Day versus 1-Day Acuvue Moist each for one week of daily disposable wear.

What is the current status of trial NCT02024698?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-01. Estimated completion is 2014-03.

What interventions are being tested in trial NCT02024698?

The interventions under investigation include: etafilcon A (DEVICE), omafilcon A (DEVICE).

Who is sponsoring clinical trial NCT02024698?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02024698's enrollment target sits among peer trials

43 1435th of 2000 higher than 565 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02024698, the US trial registry maintained by the National Library of Medicine. NCT02024698 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.